Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 15, 2024
miR-203 modulates pregnant myometrium contractility via transient receptor potential vanilloid 4 channel expressionLihua Ying, Daiana D Fornes, Amy D Dobberfuhl, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 14, 2009
A(1) adenosine receptor-mediated PKC and p42/p44 MAPK signaling in mouse coronary artery smooth muscle cellsHabib R Ansari, Bunyen Teng, Ahmed Nadeem, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|October 30, 2003
Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activationNaj A Sharif, Julie Y Crider, Shahid Husain, et al.
Oncology (Williston Park, N.Y.)|March 17, 2001
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancerK D Miller, J Sisk, R Ansari, et al.
AJOG Global Reports|June 15, 2026
Tranexamic acid use for the prevention of postpartum hemorrhage in high-income countries: a review of recent literatureSangita M Baxi, Irogue I Igbinosa, Elliott K Main, et al.
Investigational New Drugs|August 11, 1991
Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancerS Saxman, P J Loehrer, K Logie, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2009
A2A adenosine receptor deficiency leads to impaired tracheal relaxation via NADPH oxidase pathway in allergic miceA Nadeem, D S Ponnoth, H R Ansari, et al.
American Journal of Clinical Oncology|February 22, 2000
Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer: a Hoosier Oncology Group TrialG Sonpavde, R Ansari, P Walker, et al.
Pageof 20